华森制药实控人方3个月套现1亿 控股股东去年套现2亿

Core Viewpoint - The announcement details the share reduction plans of Huason Pharmaceutical's controlling shareholders, indicating significant changes in ownership structure and potential impacts on stock performance [1][2]. Share Reduction Plans - The controlling shareholder, You Hongtao, plans to reduce his holdings by up to 6,649,826 shares, representing 1.59% of the total share capital, through block trading from November 6, 2025, to February 5, 2026 [1]. - Shanghai Tiancheng Investment Management Co., Ltd. plans to reduce its holdings by a total of 5,878,000 shares, which is 1.41% of the total share capital, through both centralized bidding and block trading during the same period [1][2]. Reduction Results - As of February 5, 2026, You Hongtao reduced 5,965,965 shares at an average price of 14.18 yuan per share, while the Tiancheng Fund reduced 1,429,480 shares at an average price of 15.64 yuan per share, totaling 7,395,445 shares and approximately 107 million yuan in cash [2][3]. Shareholder Structure - You Hongtao is one of the actual controllers of Huason Pharmaceutical and is also the chairman and general manager. The actual controllers include You Yizhu, You Hongtao, and Wang Ying, with a combined holding of 68.00% as of June 30, 2025 [4]. Previous Reductions - Chengdu Local Construction Machinery Engineering Co., Ltd. previously reduced its holdings by 12,527,826 shares, accounting for 3.00% of the total share capital, with a cash inflow estimated between 194 million yuan and 216 million yuan [5].